{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:20:13Z","timestamp":1792678813398,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,7,3]],"date-time":"2011-07-03T00:00:00Z","timestamp":1309651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/nn.2858","type":"journal-article","created":{"date-parts":[[2011,7,4]],"date-time":"2011-07-04T09:04:46Z","timestamp":1309770286000},"page":"1023-1032","source":"Crossref","is-referenced-by-count":272,"title":["Potent amyloidogenicity and pathogenicity of A\u03b243"],"prefix":"10.1038","volume":"14","author":[{"given":"Takashi","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Suemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristel","family":"Sleegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Funamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Mihira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Matsuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Van Broeckhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi C","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,3]]},"reference":[{"key":"BFnn2858_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow, K., de Leon, M.J. & Zetterberg, H. Alzheimer's disease. Lancet 368, 387\u2013403 (2006).","journal-title":"Lancet"},{"key":"BFnn2858_CR2","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1021\/bi0508237","volume":"44","author":"L Miravalle","year":"2005","unstructured":"Miravalle, L. et al. Amino-terminally truncated A\u03b2 peptide species are the main component of cotton wool plaques. Biochemistry 44, 10810\u201310821 (2005).","journal-title":"Biochemistry"},{"key":"BFnn2858_CR3","doi-asserted-by":"publisher","first-page":"10317","DOI":"10.1021\/bi700951u","volume":"46","author":"GD Van Vickle","year":"2007","unstructured":"Van Vickle, G.D. et al. TgCRND8 amyloid precursor protein transgenic mice exhibit an altered \u03b3-secretase processing and an aggressive, additive amyloid pathology subject to immunotherapeutic modulation. Biochemistry 46, 10317\u201310327 (2007).","journal-title":"Biochemistry"},{"key":"BFnn2858_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0006-8993(95)01163-2","volume":"702","author":"T Iizuka","year":"1995","unstructured":"Iizuka, T. et al. Amyloid \u03b2-protein ending at Thr43 is a minor component of some diffuse plaques in the Alzheimer's disease brain, but is not found in cerebrovascular amyloid. Brain Res. 702, 275\u2013278 (1995).","journal-title":"Brain Res."},{"key":"BFnn2858_CR5","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1001\/archneur.58.12.2025","volume":"58","author":"S Parvathy","year":"2001","unstructured":"Parvathy, S. et al. Correlation between A\u00dfx-40-, A\u00dfx-42- and A\u00dfx-43-containing amyloid plaques and cognitive decline. Arch. Neurol. 58, 2025\u20132032 (2001).","journal-title":"Arch. Neurol."},{"key":"BFnn2858_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1471-4159.2009.06170.x","volume":"110","author":"H Welander","year":"2009","unstructured":"Welander, H. et al. A\u03b243 is more frequent than A\u03b240 in amyloid plaque cores from Alzheimer disease brains. J. Neurochem. 110, 697\u2013706 (2009).","journal-title":"J. Neurochem."},{"key":"BFnn2858_CR7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/ejhg.2010.107","volume":"18","author":"L Keller","year":"2010","unstructured":"Keller, L. et al. The PSEN1 I143T mutation in a Swedish family with Alzheimer's disease: clinical report and quantification of A\u03b2 in different brain regions. Eur. J. Hum. Genet. 18, 1202\u20131208 (2010).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnn2858_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1523\/JNEUROSCI.1575-04.2005","volume":"25","author":"Y Qi-Takahara","year":"2005","unstructured":"Qi-Takahara, Y. et al. Longer forms of amyloid \u03b2 protein: implications for the mechanism of intramembrane cleavage by \u03b3-secretase. J. Neurosci. 25, 436\u2013445 (2005).","journal-title":"J. Neurosci."},{"key":"BFnn2858_CR9","doi-asserted-by":"publisher","first-page":"13042","DOI":"10.1523\/JNEUROSCI.2362-09.2009","volume":"29","author":"M Takami","year":"2009","unstructured":"Takami, M. et al. \u03b3-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of \u03b2-carboxyl terminal fragment. J. Neurosci. 29, 13042\u201313052 (2009).","journal-title":"J. Neurosci."},{"key":"BFnn2858_CR10","doi-asserted-by":"publisher","first-page":"16488","DOI":"10.1074\/jbc.M801279200","volume":"283","author":"M Shimojo","year":"2008","unstructured":"Shimojo, M. et al. Enzymatic characteristics of I213T mutant Presenilin-1\/\u03b3-secretase in cell models and knock-in mouse brains: FAD-linked mutation impairs \u03b3-site cleavage of APP-CTF\u03b2. J. Biol. Chem. 283, 16488\u201316496 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR11","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"JT Jarrett","year":"1993","unstructured":"Jarrett, J.T., Berger, E.P. & Lansbury, P.T. Jr. The carboxy terminus of the \u03b2 amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693\u20134697 (1993).","journal-title":"Biochemistry"},{"key":"BFnn2858_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1073\/pnas.222681699","volume":"100","author":"G Bitan","year":"2003","unstructured":"Bitan, G. et al. Amyloid \u03b2-protein (A\u03b2) assembly: A\u03b240 and A\u03b242 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100, 330\u2013335 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2858_CR13","doi-asserted-by":"publisher","first-page":"19070","DOI":"10.1074\/jbc.M501130200","volume":"280","author":"Y Nakaya","year":"2005","unstructured":"Nakaya, Y. et al. Random mutagenesis of presenilin-1 identifies novel mutants exclusively generating long amyloid \u03b2-peptides. J. Biol. Chem. 280, 19070\u201319077 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR14","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/01.WNL.0000143060.98164.1A","volume":"63","author":"AK Godbolt","year":"2004","unstructured":"Godbolt, A.K. et al. A presenilin 1 R278I mutation presenting with language impairment. Neurology 63, 1702\u20131704 (2004).","journal-title":"Neurology"},{"key":"BFnn2858_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0092-8674(00)80244-5","volume":"89","author":"J Shen","year":"1997","unstructured":"Shen, J. et al. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89, 629\u2013639 (1997).","journal-title":"Cell"},{"key":"BFnn2858_CR16","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/387288a0","volume":"387","author":"PC Wong","year":"1997","unstructured":"Wong, P.C. et al. Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm. Nature 387, 288\u2013292 (1997).","journal-title":"Nature"},{"key":"BFnn2858_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1432-1033.2003.03936.x","volume":"271","author":"JG Culvenor","year":"2003","unstructured":"Culvenor, J.G. et al. Characterization of presenilin complexes from mouse and human brain using blue native gel electrophoresis reveals high expression in embryonic brain and minimal change in complex mobility with pathogenic presenilin mutations. Eur. J. Biochem. 271, 375\u2013385 (2003).","journal-title":"Eur. J. Biochem."},{"key":"BFnn2858_CR18","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1021\/bi0481702","volume":"44","author":"G Evin","year":"2005","unstructured":"Evin, G. et al. Transition-state analogue \u03b3-secretase inhibitors stabilize a 900 kDa presenilin\/nicastrin complex. Biochemistry 44, 4332\u20134341 (2005).","journal-title":"Biochemistry"},{"key":"BFnn2858_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80291-3","volume":"17","author":"G Thinakaran","year":"1996","unstructured":"Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181\u2013190 (1996).","journal-title":"Neuron"},{"key":"BFnn2858_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nm0797-756","volume":"3","author":"MK Lee","year":"1997","unstructured":"Lee, M.K. et al. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo. Nat. Med. 3, 756\u2013760 (1997).","journal-title":"Nat. Med."},{"key":"BFnn2858_CR21","doi-asserted-by":"publisher","first-page":"13092","DOI":"10.1523\/JNEUROSCI.4244-07.2007","volume":"27","author":"H Kaneko","year":"2007","unstructured":"Kaneko, H. et al. Enhanced accumulation of phosphorylated \u03b1-synuclein and elevated \u03b2-amyloid 42\/40 ratio caused by expression of the presenilin-1 \u0394T440 mutant associated with familial Lewy body disease and variant Alzheimer's disease. J. Neurosci. 27, 13092\u201313097 (2007).","journal-title":"J. Neurosci."},{"key":"BFnn2858_CR22","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1735338100","volume":"100","author":"EH Schroeter","year":"2003","unstructured":"Schroeter, E.H. et al. A presenilin dimer at the core of the \u03b3-secretase enzyme: insight from parallel analysis of Notch1 and APP proteolysis. Proc. Natl. Acad. Sci. USA 100, 13075\u201313080 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2858_CR23","doi-asserted-by":"publisher","first-page":"30259","DOI":"10.1074\/jbc.M401891200","volume":"279","author":"E Hama","year":"2004","unstructured":"Hama, E., Shirotani, K., Iwata, N. & Saido, T.C. Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid \u03b2 peptide clearance in primary neurons. J. Biol. Chem. 279, 30259\u201330264 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/humu.20336","volume":"27","author":"S Kumar-Singh","year":"2006","unstructured":"Kumar-Singh, S. et al. Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased A\u03b242 and decreased A\u03b240. Hum. Mutat. 27, 686\u2013695 (2006).","journal-title":"Hum. Mutat."},{"key":"BFnn2858_CR25","doi-asserted-by":"publisher","first-page":"15330","DOI":"10.1074\/jbc.M512574200","volume":"281","author":"R Wang","year":"2006","unstructured":"Wang, R., Wang, B., He, W. & Zheng, H. Wild-type presenilin 1 protects against Alzheimer disease mutation\u2013induced amyloid pathology. J. Biol. Chem. 281, 15330\u201315336 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR26","doi-asserted-by":"publisher","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","volume":"27","author":"J Maeda","year":"2007","unstructured":"Maeda, J. et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J. Neurosci. 27, 10957\u201310968 (2007).","journal-title":"J. Neurosci."},{"key":"BFnn2858_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0896-6273(95)90301-1","volume":"14","author":"TC Saido","year":"1995","unstructured":"Saido, T.C. et al. Dominant and differential deposition of distinct \u03b2-amyloid peptide species, A\u00dfN3(pE), in senile plaques. Neuron 14, 457\u2013466 (1995).","journal-title":"Neuron"},{"key":"BFnn2858_CR28","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/nm.1872","volume":"14","author":"S Schilling","year":"2008","unstructured":"Schilling, S. et al. Glutaminyl cyclase inhibition attenuates pyroglutamate A\u03b2 and Alzheimer's disease\u2013like pathology. Nat. Med. 14, 1106\u20131111 (2008).","journal-title":"Nat. Med."},{"key":"BFnn2858_CR29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nature08177","volume":"460","author":"C Zhang","year":"2009","unstructured":"Zhang, C. et al. Presenilins are essential for regulating neurotransmitter release. Nature 460, 632\u2013636 (2009).","journal-title":"Nature"},{"key":"BFnn2858_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/35014735","volume":"405","author":"C Russo","year":"2000","unstructured":"Russo, C. et al. Presenilin-1 mutations in Alzheimer's disease. Nature 405, 531\u2013532 (2000).","journal-title":"Nature"},{"key":"BFnn2858_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","volume":"47","author":"E McGowan","year":"2005","unstructured":"McGowan, E. et al. A\u03b242 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47, 191\u2013199 (2005).","journal-title":"Neuron"},{"key":"BFnn2858_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1523\/JNEUROSCI.4849-06.2007","volume":"27","author":"J Kim","year":"2007","unstructured":"Kim, J. et al. A\u03b240 inhibits amyloid deposition in vivo. J. Neurosci. 27, 627\u2013633 (2007).","journal-title":"J. Neurosci."},{"key":"BFnn2858_CR33","doi-asserted-by":"publisher","first-page":"23186","DOI":"10.1074\/jbc.M109.086496","volume":"285","author":"K Ono","year":"2010","unstructured":"Ono, K., Condron, M. & Teplow, D.B. Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid \u03b2-protein assembly and toxicity. J. Biol. Chem. 285, 23186\u201323197 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR34","doi-asserted-by":"publisher","first-page":"28176","DOI":"10.1074\/jbc.M803159200","volume":"283","author":"A Jan","year":"2008","unstructured":"Jan, A. et al. The ratio of monomeric to aggregated forms of A\u03b240 and A\u03b242 is an important determinant of amyloid-\u03b2 aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 283, 28176\u201328189 (2008).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR35","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/35016111","volume":"405","author":"SS Huppert","year":"2000","unstructured":"Huppert, S.S. et al. Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405, 966\u2013970 (2000).","journal-title":"Nature"},{"key":"BFnn2858_CR36","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1074\/jbc.M209252200","volume":"278","author":"T Ikeuchi","year":"2003","unstructured":"Ikeuchi, T. et al. Familial Alzheimer disease-linked presenilin 1 variants enhance production of both A\u03b21\u201340 and A\u03b21\u201342 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of \u201c\u03b3-secretase\u201d. J. Biol. Chem. 278, 7010\u20137018 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR37","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1126\/science.1171176","volume":"324","author":"L Serneels","year":"2009","unstructured":"Serneels, L. et al. \u03b3-Secretase heterogeneity in the Aph1 subunit: relevance for Alzheimer's disease. Science 324, 639\u2013642 (2009).","journal-title":"Science"},{"key":"BFnn2858_CR38","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1471-4159.2005.03578.x","volume":"96","author":"M Bentahir","year":"2006","unstructured":"Bentahir, M. et al. Presenilin clinical mutations can affect \u03b3-secretase activity by different mechanisms. J. Neurochem. 96, 732\u2013742 (2006).","journal-title":"J. Neurochem."},{"key":"BFnn2858_CR39","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1523\/JNEUROSCI.5384-05.2006","volume":"26","author":"Y Deng","year":"2006","unstructured":"Deng, Y. et al. Deletion of presenilin 1 hydrophilic loop sequence leads to imparired \u03b3-secretase activity and exacerbated amyloid pathology. J. Neurosci. 26, 3845\u20133854 (2006).","journal-title":"J. Neurosci."},{"key":"BFnn2858_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3233\/JAD-2004-6504","volume":"6","author":"H Hara","year":"2004","unstructured":"Hara, H. et al. Development of a safe oral A\u03b2 vaccine using recombinant adeno-associated virus vector for Alzheimer's disease. J. Alzheimers Dis. 6, 483\u2013488 (2004).","journal-title":"J. Alzheimers Dis."},{"key":"BFnn2858_CR41","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1096\/fj.06-7685com","volume":"21","author":"A Mouri","year":"2007","unstructured":"Mouri, A. et al. Oral vaccination with a viral vector containing A\u03b2 cDNA attenuates age-related A\u03b2 accumulation and memory deficits without causing inflammation in a mouse Alzheimer model. FASEB J. 21, 2135\u20132148 (2007).","journal-title":"FASEB J."},{"key":"BFnn2858_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1538\/expanim.50.77","volume":"50","author":"N Kimura","year":"2001","unstructured":"Kimura, N. et al. Senile plaques in an aged Western Lowland Gorilla. Exp. Anim. 50, 77\u201381 (2001).","journal-title":"Exp. Anim."},{"key":"BFnn2858_CR43","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat, C. et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease\u2013like pathology. Proc. Natl. Acad. Sci. USA 94, 13287\u201313292 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2858_CR44","doi-asserted-by":"publisher","first-page":"17941","DOI":"10.1074\/jbc.M601372200","volume":"281","author":"S-M Huang","year":"2006","unstructured":"Huang, S.-M. et al. Neprilysin-sensitive synapse-associated amyloid-\u03b2 peptide oligomers impair neuronal plasticity and cognitive function. J. Biol. Chem. 281, 17941\u201317951 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnn2858_CR45","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1073\/pnas.93.4.1683","volume":"93","author":"R Kopan","year":"1996","unstructured":"Kopan, R., Schroeter, E.H., Weintraub, H. & Nye, J.S. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc. Natl. Acad. Sci. USA 93, 1683\u20131688 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnn2858_CR46","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1523\/JNEUROSCI.4792-03.2004","volume":"24","author":"N Iwata","year":"2004","unstructured":"Iwata, N. et al. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-\u03b2 peptide in mouse brain. J. Neurosci. 24, 991\u2013998 (2004).","journal-title":"J. Neurosci."},{"key":"BFnn2858_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","volume":"13","author":"T Iwatsubo","year":"1994","unstructured":"Iwatsubo, T. et al. Visualization of A\u03b242(43) and A\u03b240 in senile plaques with end-specific A\u03b2 monoclonals: evidence that an initially deposited species is A\u03b242(43). Neuron 13, 45\u201353 (1994).","journal-title":"Neuron"},{"key":"BFnn2858_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0002-9440(10)65273-X","volume":"154","author":"M Enya","year":"1999","unstructured":"Enya, M. et al. Appearance of sodium dodecylsulfate-stable amyloid \u03b2-protein (A\u03b2) dimer in the cortex during aging. Am. J. Pathol. 154, 271\u2013279 (1999).","journal-title":"Am. J. Pathol."},{"key":"BFnn2858_CR49","first-page":"171","volume":"190","author":"DA Ryan","year":"2010","unstructured":"Ryan, D.A., Narrow, W.C., Federoff, H.J. & Bowers, W.J. An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studies. J. Neurosci. Res. 190, 171\u2013179 (2010).","journal-title":"J. Neurosci. Res."},{"key":"BFnn2858_CR50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/1096-8628(20011001)103:2<138::AID-AJMG1529>3.0.CO;2-8","volume":"103","author":"D Arango","year":"2001","unstructured":"Arango, D. et al. Systemic genetic study of Alzheimer disease in Latin America: mutation frequencies of the amyloid \u03b2 precursor protein and presenilin gene in Colombia. Am. J. Med. Genet. 103, 138\u2013143 (2001).","journal-title":"Am. J. Med. Genet."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nn.2858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.2858","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nn.2858.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:08:34Z","timestamp":1684454914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nn.2858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,3]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["BFnn2858"],"URL":"https:\/\/doi.org\/10.1038\/nn.2858","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,3]]}}}